Literature DB >> 25725788

Myostatin induces interstitial fibrosis in the heart via TAK1 and p38.

Nadine Biesemann1, Luca Mendler, Sawa Kostin, Astrid Wietelmann, Thilo Borchardt, Thomas Braun.   

Abstract

Myostatin, a member of the TGF-β superfamily of secreted growth factors, is a negative regulator of skeletal muscle growth. In the heart, it is expressed at lower levels compared to skeletal muscle but up-regulated under disease conditions. Cre recombinase-mediated inactivation of myostatin in adult cardiomyocytes leads to heart failure and increased mortality but cardiac function of surviving mice is restored after several weeks probably due to compensatory expression in non-cardiomyocytes. To study long-term effects of increased myostatin expression in the heart and to analyze the putative crosstalk between cardiomyocytes and fibroblasts, we overexpressed myostatin in cardiomyocytes. Increased expression of myostatin in heart muscle cells caused interstitial fibrosis via activation of the TAK-1-MKK3/6-p38 signaling pathway, compromising cardiac function in older mice. Our results uncover a novel role of myostatin in the heart and highlight the necessity for tight regulation of myostatin to maintain normal heart function.

Entities:  

Mesh:

Substances:

Year:  2015        PMID: 25725788     DOI: 10.1007/s00441-015-2139-2

Source DB:  PubMed          Journal:  Cell Tissue Res        ISSN: 0302-766X            Impact factor:   5.249


  23 in total

1.  GDF11 Decreases Pressure Overload-Induced Hypertrophy, but Can Cause Severe Cachexia and Premature Death.

Authors:  Shavonn C Harper; Jaslyn Johnson; Giulia Borghetti; Huaqing Zhao; Tao Wang; Markus Wallner; Hajime Kubo; Eric A Feldsott; Yijun Yang; Yunichel Joo; Xinji Gou; Abdel Karim Sabri; Priyanka Gupta; Maria Myzithras; Ashraf Khalil; Michael Franti; Steven R Houser
Journal:  Circ Res       Date:  2018-11-09       Impact factor: 17.367

2.  Maternal chromium restriction modulates miRNA profiles related to lipid metabolism disorder in mice offspring.

Authors:  Qian Zhang; Xinhua Xiao; Jia Zheng; Ming Li; Miao Yu; Fan Ping; Zhixin Wang; Cuijuan Qi; Tong Wang; Xiaojing Wang
Journal:  Exp Biol Med (Maywood)       Date:  2017-07-01

3.  Steps toward therapeutically targeting the activin type II receptor for treating heart failure.

Authors:  Samantha J Paddock; Caitlin C O'Meara
Journal:  Am J Physiol Heart Circ Physiol       Date:  2020-01-10       Impact factor: 4.733

4.  Curcumin administration suppresses collagen synthesis in the hearts of rats with experimental diabetes.

Authors:  Shuang Guo; Xiang-Wen Meng; Xiao-Song Yang; Xiu-Fen Liu; Chang-Han Ou-Yang; Chao Liu
Journal:  Acta Pharmacol Sin       Date:  2017-09-14       Impact factor: 6.150

Review 5.  Biochemistry and Biology of GDF11 and Myostatin: Similarities, Differences, and Questions for Future Investigation.

Authors:  Ryan G Walker; Tommaso Poggioli; Lida Katsimpardi; Sean M Buchanan; Juhyun Oh; Sam Wattrus; Bettina Heidecker; Yick W Fong; Lee L Rubin; Peter Ganz; Thomas B Thompson; Amy J Wagers; Richard T Lee
Journal:  Circ Res       Date:  2016-04-01       Impact factor: 17.367

6.  Activin type II receptor ligand signaling inhibition after experimental ischemic heart failure attenuates cardiac remodeling and prevents fibrosis.

Authors:  Estibaliz Castillero; Hirokazu Akashi; Marc Najjar; Ruiping Ji; Lea Maria Brandstetter; Catherine Wang; Xianghai Liao; Xiaokan Zhang; Alexandra Sperry; Marcia Gailes; Karina Guaman; Adam Recht; Ira Schlosberg; H Lee Sweeney; Ziad A Ali; Shunichi Homma; Paolo C Colombo; Giovanni Ferrari; P Christian Schulze; Isaac George
Journal:  Am J Physiol Heart Circ Physiol       Date:  2019-12-30       Impact factor: 4.733

Review 7.  The case for inhibiting p38 mitogen-activated protein kinase in heart failure.

Authors:  Pelin Arabacilar; Michael Marber
Journal:  Front Pharmacol       Date:  2015-05-12       Impact factor: 5.810

Review 8.  Candidate rejuvenating factor GDF11 and tissue fibrosis: friend or foe?

Authors:  Jan Frohlich; Manlio Vinciguerra
Journal:  Geroscience       Date:  2020-10-06       Impact factor: 7.713

Review 9.  New Treatment Strategies for Alcohol-Induced Heart Damage.

Authors:  Joaquim Fernández-Solà; Ana Planavila Porta
Journal:  Int J Mol Sci       Date:  2016-09-29       Impact factor: 5.923

Review 10.  Targeting TGF-β Mediated SMAD Signaling for the Prevention of Fibrosis.

Authors:  Kelly L Walton; Katharine E Johnson; Craig A Harrison
Journal:  Front Pharmacol       Date:  2017-07-14       Impact factor: 5.810

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.